Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip McGuire

Showing results (41-50 of 514) with videos related to

Pageof 52
Sort By:
The Lancet. Psychiatry|March 6, 2017
Can we make cannabis safer?Amir Englund, Tom P Freeman, Robin M Murray, et al.
Journal of Psychiatric Research|November 28, 2022
Haematological point of care testing for clozapine monitoringMatthew Atkins, Philip McGuire, Bhirundra Balgobin, et al.
Therapeutic Advances in Psychopharmacology|April 15, 2021
Using a fingerstick test for haematological monitoring in patients treated with clozapineMatthew Atkins, Philip McGuire, Bhirundra Balgobin, et al.
Neuroscience and Biobehavioral Reviews|December 1, 2010
Dysconnectivity in schizophrenia: where are we now?William Pettersson-Yeo, Paul Allen, Stefania Benetti, et al.
Brain Sciences|April 28, 2019
Descriptive Psychopathology of the Acute Effects of Intravenous Delta-9-Tetrahydrocannabinol Administration in HumansMarco Colizzi, Nathalie Weltens, Philip McGuire, et al.
Journal of Child Psychology and Psychiatry, and Allied Disciplines|November 7, 2017
A twin study exploring the association between childhood emotional and behaviour problems and specific psychotic experiences in a community sample of adolescentsSania Shakoor, Philip McGuire, Alastair G Cardno, et al.
The American Journal of Psychiatry|December 3, 2008
Longitudinal PET imaging in a patient with schizophrenia did not show marked changes in dopaminergic function with relapse of psychosisIsabel Valli, Oliver Howes, Peter Tyrer, et al.
Neuroimage. Clinical|March 10, 2017
Meta-analysis of associations between childhood adversity and hippocampus and amygdala volume in non-clinical and general population samplesMaria Calem, Konstantinos Bromis, Philip McGuire, et al.
Schizophrenia Research|January 19, 2025
Sub-clinical systemic inflammation as a determinant of admission duration in psychosisGraham Blackman, James DeLaney, James H MacCabe, et al.
Therapeutic Advances in Psychopharmacology|September 25, 2020
Lack of evidence for the effectiveness or safety of over-the-counter cannabidiol productsEdward Chesney, Philip McGuire, Tom P Freeman, et al.
Pageof 52

Showing results (41-50 of 514) with videos related to

Sort By:
Pageof 52
The Lancet. Psychiatry|March 6, 2017
Can we make cannabis safer?Amir Englund, Tom P Freeman, Robin M Murray, et al.
Journal of Psychiatric Research|November 28, 2022
Haematological point of care testing for clozapine monitoringMatthew Atkins, Philip McGuire, Bhirundra Balgobin, et al.
Therapeutic Advances in Psychopharmacology|April 15, 2021
Using a fingerstick test for haematological monitoring in patients treated with clozapineMatthew Atkins, Philip McGuire, Bhirundra Balgobin, et al.
Neuroscience and Biobehavioral Reviews|December 1, 2010
Dysconnectivity in schizophrenia: where are we now?William Pettersson-Yeo, Paul Allen, Stefania Benetti, et al.
Brain Sciences|April 28, 2019
Descriptive Psychopathology of the Acute Effects of Intravenous Delta-9-Tetrahydrocannabinol Administration in HumansMarco Colizzi, Nathalie Weltens, Philip McGuire, et al.
Journal of Child Psychology and Psychiatry, and Allied Disciplines|November 7, 2017
A twin study exploring the association between childhood emotional and behaviour problems and specific psychotic experiences in a community sample of adolescentsSania Shakoor, Philip McGuire, Alastair G Cardno, et al.
The American Journal of Psychiatry|December 3, 2008
Longitudinal PET imaging in a patient with schizophrenia did not show marked changes in dopaminergic function with relapse of psychosisIsabel Valli, Oliver Howes, Peter Tyrer, et al.
Neuroimage. Clinical|March 10, 2017
Meta-analysis of associations between childhood adversity and hippocampus and amygdala volume in non-clinical and general population samplesMaria Calem, Konstantinos Bromis, Philip McGuire, et al.
Schizophrenia Research|January 19, 2025
Sub-clinical systemic inflammation as a determinant of admission duration in psychosisGraham Blackman, James DeLaney, James H MacCabe, et al.
Therapeutic Advances in Psychopharmacology|September 25, 2020
Lack of evidence for the effectiveness or safety of over-the-counter cannabidiol productsEdward Chesney, Philip McGuire, Tom P Freeman, et al.
Pageof 52